Naltrexona Accord (Naltrexone Hydrochloride)

Naltrexone, the active ingredient in Naltrexona Accord, is an opioid antagonist presented as an oral formulation for oral use. It is employed in the management of alcohol and opioid dependence in adult patients.

GNH USA supplies Naltrexona Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for importers.

Naltrexona Accord is used to treat disorders related to opioid and alcohol dependence.

- Alcohol dependence: reduces cravings and helps maintain abstinence in adults. - Opioid dependence: blocks opioid receptors to prevent relapse and diminish the rewarding effects of opioids.

Naltrexona Accord may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Headache - Dizziness - Fatigue - Insomnia - Abdominal pain

Serious or Rare Side Effects: - Hepatotoxicity - Severe allergic reactions (anaphylaxis, angioedema) - Elevated liver enzymes - Depression or suicidal thoughts

Before initiating therapy with Naltrexona Accord, several safety considerations should be observed.

- Liver function monitoring: assess baseline hepatic enzymes and repeat periodically. - Concomitant opioid use: avoid as it can precipitate acute withdrawal. - Pregnancy: use only if potential benefit justifies potential risk; data are limited. - Breastfeeding: not recommended; consider alternative therapies. - Renal impairment: adjust use cautiously and monitor renal function. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original packaging.

Naltrexona Accord can interact with other medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Opioid analgesics: can cause acute withdrawal. - Disulfiram: may increase hepatotoxic risk. - Hepatotoxic drugs (e.g., isoniazid): additive liver injury.

Moderate Interactions (Monitor Closely): - Benzodiazepines: combined CNS depression may occur. - Antidepressants (SSRIs, SNRIs): monitor for mood changes. - Alcohol: may enhance hepatotoxic potential.